Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
VB-1016 by Nykode Therapeutics for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
VB-1016 is under clinical development by Nykode Therapeutics and currently in Phase II for Recurrent Head And Neck Squamous Cell...
Data Insights
VB-1016 by Nykode Therapeutics for Cervical Cancer: Likelihood of Approval
VB-1016 is under clinical development by Nykode Therapeutics and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...